{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:40:45Z","timestamp":1793364045197,"version":"4.5.0"},"reference-count":188,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Targets"],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.1080\/14728222.2021.1881062","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T07:31:58Z","timestamp":1611387118000},"page":"87-100","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":26,"title":["A vasculature-centric approach to developing novel treatment options for glioblastoma"],"prefix":"10.1080","volume":"25","author":[{"given":"Hans-Georg","family":"Wirsching","sequence":"first","affiliation":[{"name":"Department of Neurology University Hospital and University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Roth","sequence":"additional","affiliation":[{"name":"Department of Neurology University Hospital and University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weller","sequence":"additional","affiliation":[{"name":"Department of Neurology University Hospital and University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197111182852108"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00038.2010"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1126\/science.1104819"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.08.039"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1545-1"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz150"},{"key":"cit0007","doi-asserted-by":"crossref","unstructured":"Bailey P, Cushing H. Microchemical color reactions as an aid to the identification and classification of brain tumors. Proc Natl Acad Sci U S A.\u00a01925 Jan;11(1):82\u20134.","DOI":"10.1073\/pnas.11.1.82"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611977"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30194-8"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.8721"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.3055"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707358"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1308345"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1308573"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1038\/nature05236"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1038\/nature11287"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.12.029"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-454"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.11.020"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4415"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-4269"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1002\/stem.429"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2010.01.001"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.06.006"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2017.10.002"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1767"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.02.021"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1903542116"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1375"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19804"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-018-9621-x"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-200606000-00001"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.03.018"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq042"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.07.003"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C100428200"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1038\/28867"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6577"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.05.018"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72290-2"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.2027"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29566"},{"key":"cit0044","doi-asserted-by":"crossref","unstructured":"Flamier A, Abdouh M, Hamam R, et al. Off-target effect of the BMI1 inhibitor PTC596 drives epithelial-mesenchymal transition in glioblastoma multiforme. NPJ Precis Oncol. 2020 Jan 6;4(1):1.","DOI":"10.1038\/s41698-019-0106-1"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.06.024"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1126\/science.1254257"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2017.01.010"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-010-9224-5"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1080\/14756360902784425"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1101\/gad.261982.115"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1478"},{"key":"cit0052","doi-asserted-by":"crossref","unstructured":"Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov.\u00a02011 Sep 16;10(10):767\u201377.","DOI":"10.1038\/nrd3554"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1038\/nature04871"},{"key":"cit0054","unstructured":"Wykoff CC, Beasley Nj, Fau Watson PH, Watson Ph Fau Turner KJ, et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 2000 Dec 15;60(24):7075\u201383."},{"key":"cit0055","doi-asserted-by":"crossref","unstructured":"Cetin BA-O, Gonul II, Gumusay O, et al. Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme. Neuropathology. 2018 Oct;38(5):457-462.","DOI":"10.1111\/neup.12485"},{"key":"cit0056","doi-asserted-by":"crossref","unstructured":"Flavahan WA, Wu QF, Hitomi M, et al. Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake. Nat Neurosci.\u00a02013 Oct;16(10):1373-82.","DOI":"10.1038\/nn.3510"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2014.10.006"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3455"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.11.021"},{"key":"cit0060","doi-asserted-by":"crossref","unstructured":"Batchelor TT, Fau GE, KE E, et al. Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation. Proc Natl Acad Sci U S A.\u00a02013 Nov 19;110(47):19059-64.","DOI":"10.1073\/pnas.1318022110"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3289"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.10.088"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0181-9"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-016-0510-y"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1739"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy120"},{"issue":"1","key":"cit0067","first-page":"23","volume":"27","author":"Wirsching HG","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"6","key":"cit0068","first-page":"553","volume":"6","author":"Winkler F","year":"2004","journal-title":"Cancer Cell"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1525360113"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1525349113"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1775"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(96)00377-2"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-019-09691-z"},{"key":"cit0074","doi-asserted-by":"crossref","unstructured":"Caspani EM, Crossley PH, Redondo-Garcia C, et al. Glioblastoma: a pathogenic crosstalk between tumor cells and pericytes. PLoS One.\u00a02014 Jul 17;9(7):e101402.","DOI":"10.1371\/journal.pone.0101402"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.03.020"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1818322116"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20850"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2014.06.003"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.9575"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4197"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0823"},{"key":"cit0082","doi-asserted-by":"crossref","unstructured":"Di Tomaso E, Snuderl MF, WS K, et al. Glioblastoma recurrence after cediranib therapy in patients: lack of \u201crebound\u201d revascularization as mode of escape. Cancer Res.\u00a02011 Jan 1;71(1):19-28.","DOI":"10.1158\/0008-5472.CAN-10-2602"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1314239110"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-0380-6"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3825-10.2011"},{"key":"cit0086","doi-asserted-by":"crossref","unstructured":"Seifert S, Sontheimer H Bradykinin enhances invasion of malignant glioma into the brain parenchyma by inducing cells to undergo amoeboid migration. J Physiol.\u00a02014 Nov 15;592(22):5109-27.","DOI":"10.1113\/jphysiol.2014.274498"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13295"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.02.005"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2016.1208082"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1025"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1355"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45535-y"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24595"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0706-x"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0684"},{"key":"cit0096","doi-asserted-by":"crossref","unstructured":"Le Joncour V, Filppu P, Hyv\u00f6nen M, et al. Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization. EMBO Mol Med.\u00a02019 Jun;11(6):e9034.","DOI":"10.15252\/emmm.201809034"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.14845"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-380006"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.04.003"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-3153"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0116-x"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0382-x"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0224-7"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.02.005"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1038\/nri3064"},{"key":"cit0107","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2444"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4185"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.03.023"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.04.055"},{"key":"cit0111","doi-asserted-by":"crossref","unstructured":"Chongsathidkiet PA-O, Jackson C, Koyama SA-O, et al. Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors. Nat Med. 2018 Sep;24(9):1459-1468.","DOI":"10.1038\/s41591-018-0135-2"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-2617"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox081"},{"key":"cit0114","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2016.12.011"},{"key":"cit0115","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.010"},{"key":"cit0116","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2012.00089"},{"key":"cit0117","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1056442"},{"key":"cit0118","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa6204"},{"key":"cit0119","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-30651-9_9"},{"key":"cit0120","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now009"},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now112"},{"key":"cit0122","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0051-2"},{"key":"cit0123","doi-asserted-by":"crossref","unstructured":"Murdoch C, Giannoudis A Fau Lewis CE, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood.\u00a02004 Oct 15;104(8):2224-34.","DOI":"10.1182\/blood-2004-03-1109"},{"key":"cit0124","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-422758"},{"key":"cit0125","doi-asserted-by":"crossref","unstructured":"Barleon B, Sozzani SF, Zhou D, et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood. 1996 Apr 15;87(8):3336-43.","DOI":"10.1182\/blood.V87.8.3336.bloodjournal8783336"},{"key":"cit0126","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03050-0"},{"key":"cit0127","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.08.002"},{"key":"cit0128","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.007"},{"key":"cit0129","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-200931"},{"key":"cit0130","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-053504"},{"key":"cit0131","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.9"},{"key":"cit0132","doi-asserted-by":"crossref","unstructured":"Fukumura D, Kloepper J, Amoozgar Z, et al. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat Rev Clin Oncol. 2018 May;15(5):325-340.","DOI":"10.1038\/nrclinonc.2018.29"},{"key":"cit0133","doi-asserted-by":"publisher","DOI":"10.1038\/nm1096-1096"},{"key":"cit0134","doi-asserted-by":"crossref","unstructured":"Oyama T, Ran SF, Ishida T, et al. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J Immunol. 1998 Feb 1;160(3):1224-32.","DOI":"10.4049\/jimmunol.160.3.1224"},{"key":"cit0135","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-006-0234-7"},{"key":"cit0136","doi-asserted-by":"publisher","DOI":"10.1038\/nm863"},{"issue":"2","key":"cit0137","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/jcmm.14027","volume":"23","author":"Lai YS","year":"2019","journal-title":"J Cell Mol Med"},{"key":"cit0138","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-007-0441-x"},{"key":"cit0139","doi-asserted-by":"crossref","unstructured":"Ohm JE, Fau GD, GD S, et al. VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. Blood.\u00a02003 Jun 15;101(12):4878-86.","DOI":"10.1182\/blood-2002-07-1956"},{"key":"cit0140","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.468"},{"key":"cit0141","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140559"},{"key":"cit0142","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20111497"},{"key":"cit0143","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3541"},{"key":"cit0144","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3337"},{"key":"cit0145","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad3018"},{"key":"cit0146","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov245"},{"key":"cit0147","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1910856117"},{"key":"cit0148","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3597"},{"key":"cit0149","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay9924"},{"key":"cit0150","doi-asserted-by":"crossref","unstructured":"Scholz A, Harter PN, Cremer S, et al. Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol Med.\u00a02016 Jan 1;8(1):39-57.","DOI":"10.15252\/emmm.201505505"},{"key":"cit0151","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30517-X"},{"key":"cit0152","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.1024"},{"key":"cit0153","doi-asserted-by":"publisher","DOI":"10.1038\/nature22396"},{"key":"cit0154","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz226"},{"key":"cit0155","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.128217"},{"key":"cit0156","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz145"},{"key":"cit0157","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1717"},{"key":"cit0158","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9679"},{"key":"cit0159","doi-asserted-by":"publisher","DOI":"10.1002\/path.5080"},{"key":"cit0160","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3836"},{"key":"cit0161","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.12.012"},{"key":"cit0162","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.5005"},{"key":"cit0163","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa157"},{"key":"cit0164","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.8715"},{"key":"cit0165","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1620-7"},{"key":"cit0166","doi-asserted-by":"crossref","unstructured":"Kickingereder P, Sahm F, Radbruch A, et al. IDH mutation status is associated with a distinct hypoxia\/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma. Sci Rep.\u00a02015 Nov 5;5:16238.","DOI":"10.1038\/srep16238"},{"key":"cit0167","doi-asserted-by":"crossref","unstructured":"Gargini R, Segura-Collar B, Herr\u00e1nz B, et al. The IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas. Sci Transl Med.\u00a02020 Jan 22;12(527):eaax1501.","DOI":"10.1126\/scitranslmed.aax1501"},{"key":"cit0168","doi-asserted-by":"publisher","DOI":"10.1101\/gad.294991.116"},{"key":"cit0169","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-3714"},{"key":"cit0170","doi-asserted-by":"crossref","unstructured":"Kohanbash GF, DA C, Fau CD, et al. Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas. J Clin Invest.\u00a02017 Apr 3;127(4):1425-1437.","DOI":"10.1172\/JCI90644"},{"key":"cit0171","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0095-6"},{"key":"cit0172","doi-asserted-by":"crossref","unstructured":"van den Bent MJ, Klein M, Smits M, et al. Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p\/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial. Lancet Oncol.\u00a02018 Sep;19(9):1170-1179.","DOI":"10.1016\/S1470-2045(18)30362-0"},{"key":"cit0173","doi-asserted-by":"crossref","unstructured":"Batchelor TT, Mulholland P Fau Neyns B, Neyns B Fau Nabors LB, et al. Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma. J Clin Oncol.\u00a02013 Sep 10;31(26):3212-8.","DOI":"10.1200\/JCO.2012.47.2464"},{"key":"cit0174","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.204"},{"key":"cit0175","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808710"},{"key":"cit0176","doi-asserted-by":"crossref","unstructured":"Brat DJ, Aldape K, Colman H, et al. cIMPACT-NOW update 3: recommended diagnostic criteria for \u201cdiffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV\u201d. Acta Neuropathol.\u00a02018 Nov;136(5):805-810.","DOI":"10.1007\/s00401-018-1913-0"},{"key":"cit0177","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.08.024"},{"key":"cit0178","doi-asserted-by":"publisher","DOI":"10.1038\/nature26000"},{"key":"cit0179","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.12.020"},{"key":"cit0180","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3590"},{"key":"cit0181","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.02.007"},{"key":"cit0182","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.11.003"},{"key":"cit0183","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1364"},{"key":"cit0184","doi-asserted-by":"publisher","DOI":"10.1038\/nature03128"},{"key":"cit0185","doi-asserted-by":"crossref","unstructured":"M\u00fcller S, Kohanbash G, Liu SJ, et al. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment. Genome Biol.\u00a02017 Dec 20;18(1):234.","DOI":"10.1186\/s13059-017-1362-4"},{"key":"cit0186","doi-asserted-by":"crossref","unstructured":"Goveia J, Rohlenova K, Taverna F, et al. An integrated gene expression landscape profiling approach to identify lung tumor endothelial cell heterogeneity and angiogenic candidates. Cancer Cell. 2020 Jan 13;37(1):21-36.e13.","DOI":"10.1016\/j.ccell.2019.12.001"},{"key":"cit0187","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2728"},{"key":"cit0188","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.5_suppl.92"}],"container-title":["Expert Opinion on Therapeutic Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728222.2021.1881062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T22:57:25Z","timestamp":1697669845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14728222.2021.1881062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":188,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"alternative-id":["10.1080\/14728222.2021.1881062"],"URL":"https:\/\/doi.org\/10.1080\/14728222.2021.1881062","relation":{},"ISSN":["1472-8222","1744-7631"],"issn-type":[{"value":"1472-8222","type":"print"},{"value":"1744-7631","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iett20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iett20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-09-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}